Filing Details
- Accession Number:
- 0001140361-16-058008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-16 15:10:16
- Reporting Period:
- 2016-03-14
- Filing Date:
- 2016-03-16
- Accepted Time:
- 2016-03-16 15:10:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1514588 | Adam Havey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Biodefense Divison | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-03-14 | 2,701 | $33.96 | 39,163 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-03-14 | 1,658 | $33.96 | 37,505 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.67 to $34.17, inclusive.